StockpollyBeta
Get App
Popularity #2,898
CERS · NASDAQ · Medical - Devices

Cerus (CERS)

Supplies illuminators and disposable kits that inactivate pathogens in donated platelets, plasma and fibrinogen concentrate.

$2.66
After hours−0.01 (−0.24%)
At close$2.67(+4.10%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue404738454651435253585457
Cost of revenue182117202023182325282628
Gross profit222621252627252928302830
272529292729313227302831
Research & development171414151415171916161514
Selling, general & administrative161720191819202119212023
Other expenses−6−7−5−5−5−6−6−8−8−7−6−6
Operating income−51−8−4−1−1−6−31−10−2
−2−2−2−2−2−1−2−2−1−1−1−1
Interest expense222222222222
Other non-operating income00−100−100−1−1−1−1
Income before tax−7−1−10−6−3−2−8−60−2−2−3
Income tax expense000000000000
Net income from continuing operations−7−1−10−6−3−3−8−60−2−2−3
Other adjustments000000000000
Net income−7−1−10−6−3−3−8−60−2−2−3
EPS, basic−$0.04−$0.01−$0.05−$0.03−$0.02−$0.01−$0.04−$0.03−$0.00−$0.01−$0.01−$0.01
EPS, diluted−$0.04−$0.01−$0.05−$0.03−$0.02−$0.01−$0.04−$0.03−$0.00−$0.01−$0.01−$0.01
Weighted average shares, basic181181182185185185187191192192194201
Weighted average shares, diluted181181182185185185187191192192194201
EBITDA−42−7−300−5−3301−1
Depreciation & amortization111000000000
EBIT−51−7−4−10−6−3200−1